Since significant alteration of OGT and OGA was observed in SKOV3 cells after KU60019 treatment, we next evaluated the prognostic value of these genes in ovarian cancer patients, including overall survival (OS), progression-free survival (PFS), and post-progression survival (PPS). Here, OGA is linked to ovarian carcinoma.